These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 10352502
1. [Diagnostic importance of fibronectin in chronic liver diseases]. Golubović M, Majkić-Singh N, Marković S, Sumarac Z, Obradović I. Med Pregl; 1999; 52(1-2):35-8. PubMed ID: 10352502 [Abstract] [Full Text] [Related]
2. [Plasma fibronectin in chronic liver disease--marker of fibrosis?]. Simon K, Zalewska M, Gładysz A, Rotter K, Piszko P, Głowacki A. Przegl Lek; 1995; 52(4):129-32. PubMed ID: 7638358 [Abstract] [Full Text] [Related]
4. Plasma levels of fibronectin in patients with chronic viral and alcoholic liver disease. Grieco A, Matera A, Di Rocco P, Marcoccia S, Giancaterini A, Alfei B, Addolorato G, Varlese F, Gasbarrini G. Hepatogastroenterology; 1998; 45(23):1731-6. PubMed ID: 9840137 [Abstract] [Full Text] [Related]
5. The use of tissue polypeptide specific antigen as a marker in liver diseases. Cetin T, Oğuz A, Algan P, Yildirim IS. Turk J Gastroenterol; 2003 Sep; 14(3):177-80. PubMed ID: 14655061 [Abstract] [Full Text] [Related]
7. [Determination of plasma fibronectin (Fn) levels. Comparison between normal subjects and patients with various pathological conditions]. Gironi A, Niccolai J, Fabbri LP, Niccolai M, Chisci C. Quad Sclavo Diagn; 1982 Dec; 18(4):392-405. PubMed ID: 6764670 [Abstract] [Full Text] [Related]
11. [Clinical usefulness of plasma activities of gelatinase (matrix metalloproteinase-2 and 9) in chronic liver disease]. Kwon OS, Lim DY, Kwon KA, Chung MG, Park DK, Kim SS, Kim YS, Kwon SY, Koo YS, Kim YK, Choi DJ, Kim JH, Hwang YJ, Byun KS, Lee CH. Taehan Kan Hakhoe Chi; 2003 Sep; 9(3):222-30. PubMed ID: 14515040 [Abstract] [Full Text] [Related]
12. Diagnostic value of plasma fibronectin level in predicting the presence and severity of coronary artery disease. Ozcelik F, Erdogan O, Aktoz M, Ekuklu G, Tatli E, Demir M. Ann Hematol; 2009 Mar; 88(3):249-53. PubMed ID: 18716775 [Abstract] [Full Text] [Related]
16. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Naveau S, Gaudé G, Asnacios A, Agostini H, Abella A, Barri-Ova N, Dauvois B, Prévot S, Ngo Y, Munteanu M, Balian A, Njiké-Nakseu M, Perlemuter G, Poynard T. Hepatology; 2009 Jan; 49(1):97-105. PubMed ID: 19053048 [Abstract] [Full Text] [Related]
17. Changes of plasma D(-)-lactate, diamine oxidase and endotoxin in patients with liver cirrhosis. Ruan P, Gong ZJ, Zhang QR. Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):58-61. PubMed ID: 14969839 [Abstract] [Full Text] [Related]
20. Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection. Zhao L, Li T, Wang Y, Pan Y, Ning H, Hui X, Xie H, Wang J, Han Y, Liu Z, Fan D. Int J Clin Pract; 2008 Jul; 62(7):1056-62. PubMed ID: 17537188 [Abstract] [Full Text] [Related] Page: [Next] [New Search]